Literature DB >> 33213100

Risk Factors for Dementia Incidence Based on Previous Results of the Specific Health Checkups in Japan.

Yoh Tamaki1, Yoshimune Hiratsuka1,2, Toshiro Kumakawa1,3.   

Abstract

Dementia is a common disease in elderly people, with its prevalence expanding rapidly worldwide. Longitudinal and cohort studies on lifestyle and health conditions are needed to identify the risk of dementia. This study aimed to identify the risk factors for dementia incidence in Japan and to clarify the strategy for its primary care. In this study, an analysis was performed to investigate the association between the cognitive faculty level of the long-term care certification survey and the previous results of the specific health checkups in Japan. To investigate the risk factor for dementia incidence, a multivariable logistic regression analysis was performed, which showed a significant odds ratio for the incidence of dementia for two items, including abdominal circumference and insulin injections or oral hypoglycemic medications. The findings of our study suggested that a lower abdominal circumference had a higher risk for dementia incidence, and individuals who received insulin injections or oral hypoglycemic medications had a higher risk for dementia incidence based on the results of the health checkups conducted 10 years previously. Further, longer duration study with a larger sample is needed to identify the items from the specific health checkups that are associated with the risk of dementia.

Entities:  

Keywords:  abdominal circumference; checkups; dementia; long-term care; primary care; risk factor

Year:  2020        PMID: 33213100      PMCID: PMC7712562          DOI: 10.3390/healthcare8040491

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


1. Introduction

Dementia is a common disease in elderly people, with its prevalence expanding rapidly worldwide [1]. The World Health Organization (WHO) reported that the number of dementia patients is estimated to be 36 million in 2012 [2]. This report estimates that the number of people with dementia will double every 20 years, reaching 66 million by 2030 and 115 million by 2050 [3]. In 2013, the Ministry of Health, Labor, and Welfare research group reported 4.62 million dementia patients in Japan, increasing to 6.75 million by 2025 and 8.20 million by 2030 [4]. The risk of dementia increases with age, especially showing rapid growth in individuals aged 70 and above. The onset of dementia imposes a heavy burden on the patient himself/herself and on family life. Moreover, from the perspective of social security costs, concrete and standard preventive measures for dementia should be urgently established. It is necessary to clarify the risk factors for dementia to establish preventive methods. Generally, preventive methods are assigned to three stages: “primary prevention,” “secondary prevention,” and “tertiary prevention.” From the perspective of preventing the development of dementia, “primary prevention” and “secondary prevention” are especially important. Longitudinal and cohort studies on lifestyle and health conditions are needed to identify the risk of dementia. As lifestyle-related diseases, middle-aged metabolic syndrome and elderly diabetes are listed as dementia risks. Ng et al. reported that the metabolic syndrome was associated with an increased incidence of cognitive impairment and progression to dementia [5]. Furthermore, diabetes is increasingly recognized as an important risk factor of cognitive function [6,7,8,9,10,11]. However, the association of higher obesity in mid-age with the incidence of dementia is debatable. Albanese et al. in their systematic review reported increased risk of dementia due to obesity in midlife, although the association between being underweight and dementia was disputable [12]. Pedditzi et al., in their meta-analysis, suggested a positive association between obesity in midlife and later dementia, and further studies are required to assess whether weight reduction in midlife reduces risk [13]. Weight loss associated with dementia begins before the onset of the clinical syndrome and accelerates by the time of diagnosis [14]. Epidemiological evidence suggests that dementia may cause involuntary weight loss long before its clinical onset, and low BMI can appear to be detrimental to dementia [15,16,17]. However, many factors, such as depression, diabetes, hypertension, and stroke may confound or mediate the association between BMI and dementia, and the covariates of statistical models have varied significantly between previous studies [13]. Therefore, in order to eliminate these confounding factors, it is necessary to perform multivariate analysis including data such as various biochemical test values and medical history. In Japan, Yokomichi reported that underweight and diabetes were risk factors for dementia incidence and lower body mass index (BMI) was also associated with dementia incidence in elderly adults [18]. Therefore, it is critical to analyze the correlation between the incidence of dementia and being underweight by ethnic group and food culture [18]. From 2008, the Ministry of Health, Labor, and Welfare in Japan started a standard health checkup program to identify people with high risk for metabolic syndrome. The Japanese health checkup/guidance program is a health policy to prevent metabolic syndrome and reduce social security costs in the medium and long term through lifestyle interventions [19]. The specified health checkups in Japan comprise 30 items, including a physical examination to assess risk factors for metabolic syndrome, and a 23-item questionnaire. In addition, Japanese long-term care insurance is a compulsory insurance that people above the age of 40 are obliged to join. A variety of care services are provided to residents who need nursing care at cut rates [20]. For this insurance, residents over the age of 65 years (category 1) and those from 40 to 64 years (category 2) are covered. Long-term care insurance services are provided if an individual over the age of 65 needs care or support, or if those between 40 and 65 years develop an age-related disease requiring care or support [21]. In the certification process for long-term care in Japan, the Needs Certification Committee conducts a survey of a total of 74 items, including physical function, cognitive function, life function, daily activity function, behavioral disorder, and adjustment to social life. The required level of care is classified into a total of 7 levels (support needs levels 1–2 and care needs levels 1–5) [22]. The data from the care certification survey include items associated with dementia. Cognitive function comprises seven stages of daily life. In this study, an analysis was performed to investigate the association between the cognitive faculty level of the long-term care certification survey and the previous results of the specific health checkups in Japan. This study aimed to identify the risk factors for dementia incidence in Japan and to clarify the strategy for its primary care.

2. Materials and Methods

2.1. Study Population

The subjects investigated in this study were selected from 30,757 insured residents in Mishima City, Shizuoka, Japan (total population 107,000). A total of 606 persons (207 men and 399 women; average age 79.5 ± 4.27 years, range 55–84 years) who submitted to both long-term care insurance services in 2018 and a previous standard program of health checkups in 2008 were included in this study. The data of long-term care certification were analyzed to identify the association between the cognitive faculty level in 2018 and the previous results of the specific health checkups in 2008. In the long-term care certification process, the cognitive faculty level was categorized by the long-term care support specialists into a total of seven degrees of independence in daily living (I: can do on their own, IIa: monitoring needed only outside home, IIb: monitoring needed inside and outside home, IIIa: need support during day, IIIb: need support during night, IV: need support during day and night, and M: need support in nursing home). The checkup programs in this study were offered to community insured between 40 and 65 years in 2008. The checkup comprised 30 items, including physical and laboratory examination.

2.2. Statistical Analysis

Factors affecting dementia incidence were assessed using logistic regression analysis. To investigate the risk factors for dementia incidence, a multiple logistic regression analysis was simultaneously carried out to calculate the adjusted odds ratio and exclude the confounding effects. Before analysis, the patients were classified into two groups: (I, IIa, IIb) and (IIIa, IIIb, IV, M). A multivariable logistic regression analysis was performed with the cognitive faculty level as the objective variable (III–M/I–IIb) and previous results of the specific health checkups (34 items associated with age, sex laboratory test, physical examination, drug-taking behavior, and outpatient medical expenditures) as the explanatory variable. The statistical analyses described above were performed using SPSS ver. 25 and Modeler ver. 18.1 (IBM Japan Ltd., Tokyo, Japan). This study was approved by the ethics committee of the National Institute of Public Health (NIPH-IBRA #12137) and the municipal assembly of Mishima. All procedures were conducted according to the International Ethical Guidelines for Epidemiology [23], Guidelines for the Utilization of the Database for National Health Insurance Claim, Specific Medical Checkup/Health Guidance [24], and Guidelines of Security for Health Information Systems [25]. Following the guidelines above, the researchers conducted analyses after the personal data were anonymized by the local administration.

3. Results

Table 1 shows the degree of dementia in daily living used in long-term care certification.
Table 1

Degree of dementia in daily living.

CategoryDegree of Independence in Daily Living
Can do on their own
ⅡaMonitoring needed only outside home
ⅡbMonitoring needed inside and outside home
ⅢaNeed support during day
ⅢbNeed support during night
IVNeed support during day and night
MNeed support in nursing home
The descriptive statistics of the degree of dementia in daily living (2018) are shown in Figure 1.
Figure 1

Results of degree of dementia in daily living (2018).

About 22.6% of individuals above category IIIa needed support in daily living. Table 2 shows the descriptive statistics of the biochemical examinations conducted in 2008.
Table 2

Results of biochemical examination (2008).

ItemNormalFollow-UpRequires Further TestingRequires TreatmentTotal
ALP5683800606
93.7%6.3%0.0%0.0%100.0%
ALT(GPT)52168017606
86.0%11.2%0.0%2.8%100.0%
Amylase5703600606
94.1%5.9%0.0%0.0%100.0%
AST(GOT)52171014606
86.0%11.7%0.0%2.3%100.0%
Blood glucose level374161071606
61.7%26.6%0.0%11.7%100.0%
Creatinine5396700606
88.9%11.1%0.0%0.0%100.0%
Erythrocyte420165021606
69.3%27.2%0.0%3.5%100.0%
HbA1C285237084606
47.0%39.1%0.0%13.9%100.0%
HDL-cholesterol5792007606
95.5%3.3%0.0%1.2%100.0%
Hematocrit5505005606
90.9%8.3%0.0%0.8%100.0%
Hemoglobin49682027606
82.0%13.5%0.0%4.5%100.0%
LDL-cholesterol25834800606
42.6%57.4%0.0%0.0%100.0%
Leucocyte5842200606
96.4%3.6%0.0%0.0%100.0%
Neutral fat461126019606
76.1%20.8%0.0%3.1%100.0%
Platelet5901500606
97.5%2.5%0.0%0.0%100.0%
Total protein5792700606
95.5%4.5%0.0%0.0%100.0%
Total-cholesterol32623700606
53.8%39.1%0.0%0.0%100.0%
Urea nitrogen5683800606
93.7%6.3%0.0%0.0%100.0%
Uric blood482149218606
79.5%2.3%15.2%3.0%100.0%
Uric protein54633819606
90.1%0.5%6.3%3.1%100.0%
Urinary acid5475900606
90.3%9.7%0.0%0.0%100.0%
Urinary sugar5860614606
96.7%0.0%1.0%2.3%100.0%
γGTP52750029606
87.0%8.3%0.0%4.8%100.0%
The percentages above the category of follow-up were higher for low-density-lipoprotein cholesterol, total cholesterol, and glycosylated hemoglobin than for other items. Figure 2 shows the number of abnormal subjects (above the category of follow-up) for each item by the category of dementia.
Figure 2

The number of abnormal subjects for each item by the category of dementia.

To investigate the risk factor for dementia incidence, a multivariable logistic regression analysis was performed, which showed a significant odds ratio (OR) for the incidence of dementia for two items, including abdominal circumference (cm) and insulin injections or oral hypoglycemic medications (Yes/No) (Table 3). A higher abdominal circumference had a lower risk for dementia incidence (OR: 0.961, 95% CI: 0.927–0.997). Individuals who received insulin injections or oral hypoglycemic medications had a higher risk of dementia incidence than those who did not (OR: 2.635, 95% CI: 1.294–5.365). No significant OR was obtained for other biochemical examinations, physical examinations, and outpatient medical expenditures in 2008.
Table 3

Results of multivariate logistic regression analysis.

ItemMultivariate Adjusted Odds Ratio95% CIp-Value
Lower LimitUpper Limit
Age1.0380.9851.0950.161
Sex (Women/Men)0.9750.4881.9480.942
Height (cm)0.9920.9551.0320.698
Abdominal circumference (cm)0.9610.9270.9970.032
BMI1.0390.9341.1560.484
Medicine to lower blood pressure (Yes/No)0.9070.5811.4160.669
Insulin injections or oral hypoglycemic medications (Yes/No)2.6351.2945.3650.008
Medicine to lower cholesterol (Yes/No)1.0010.6301.5900.998
Systolic blood pressure (mmHg)1.0070.9901.0250.396
Diastolic blood pressure (mmHg)0.9730.9461.0010.063
ALP (+±/−)1.1220.4822.6090.790
ALT(GPT) (+±/−)1.0820.6211.8840.781
Amylase (+±/−)1.4820.6643.3080.337
AST(GOT) (+±/−)0.8830.4731.6460.695
Blood glucose level (+±/−)0.9580.7151.2850.776
Creatinine (+±/−)0.8540.4181.7470.666
Erythrocyte (+±/−)0.9220.6551.2980.640
HbA1C (+±/−)0.8570.6311.1640.322
HDL-cholesterol (+±/−)1.3630.7972.3310.257
Hematocrit (+±/−)1.4670.7632.8210.250
Hemoglobin (+±/−)0.8930.6181.2890.545
LDL-cholesterol (+±/−)1.0860.6691.7610.739
Leucocyte (+±/−)1.2220.4383.4050.702
Neutral fat (+±/−)1.1500.7951.6640.458
Platelet (+±/−)1.5540.4994.8370.446
Total protein (+±/−)0.7870.2772.2360.653
Total-cholesterol (+±/−)0.9640.7161.2980.807
Urea nitrogen (+±/−)0.5490.1931.5610.261
Uric blood (+±/−)1.1300.8971.4230.301
Uric protein (+±/−)0.9400.6841.2900.701
Urinary acid (+±/−)1.0890.5032.3620.828
Urinary sugar (+±/−)0.9730.6001.5790.913
γGPT (+±/−)1.0480.7251.5150.804
Outpatient Medical Expenditures in 20081.0001.0001.0000.609
_cons1.087 0.985

Dependent variable was classified to (IIIa, IIIb, IV, M)/(I, IIa,IIb). A Total of 34 items were entered simultaneously as the independent variables.

4. Discussion

The number of beneficiaries and eligible persons in Japan requiring long-term care under this insurance system increased from 2.2 million in 2000 to 6.6 million in 2019. About one-fifth of Japanese people above the age of 65 years are certified for long-term care [21]. In Japan, to receive long-term care services, it is mandatory to apply for the required nursing care certification and receive it from the municipality where an individual stays. In the long-term care survey, healthcare professionals assess the physical and mental status of an applicant and determine the level of care required. The results of this survey are used to determine the required care level for all applicants in Japan. The assessment data collected by this procedure are expected to be aggregated at the national level and stored in a large database. This database could be useful to identify the risk factors for dementia incidence to clarify the strategy for its primary care. Moreover, in Japan over ten years have passed since the specific medical checkup and health guidance started from 2008 [26]. A database of the National Health Insurance Claim for specific medical checkups and specific health guidance shows the difference in annual medical expenses between patients classified with and without metabolic syndrome to use in a probabilistic way to determine regional medical costs [27]. The results of these medical checkups screen people who need specific health guidance by the risk of metabolic syndrome and assign them to three levels of support (I: information service only, II: motivational support, III: active support). Those who have undergone a specific medical examination are notified of the necessary information and the need for guidance based on the examination results. The specific healthcare guidance supports the improvement of lifestyle habits, such as nutrition and exercise, according to the risk of lifestyle-related diseases. People classified as motivational and active support are offered initial counseling and a final assessment six months later. If risk factors for dementia incidence based on previous results of the specific health checkups could be identified, these guidances could provide assistance to reduce the risk of dementia with the improvement of lifestyle and by establishing preventive methods. In this study, by matching the database of specific medical checkups with long-term care certification, the risk factors for dementia incidence were identified. The results of this study showed that a lower abdominal circumference had a higher risk of dementia. Qizilbash et al. reported that being underweight in middle and old age increased the risk of dementia for two decades [28]. Nam et al. reported that a lower baseline BMI was related with increased risks of all-cause dementia, and weight loss was related with an increased risk of dementia [29]. However, Kivimäki et al. reported that high BMI was associated with an increased risk of dementia when BMI was assessed more than 20 years before the diagnosis of dementia. Conversely, low BMI was reported to be a predictor of dementia if the assessment was performed less than 10 years before diagnosis [30]. In Japan, Yokomichi reported that underweight men with dyslipidemia and underweight women with hypertension had a higher risk for dementia [14]. The results of our study were consistent with those of Yokomichi’s study. However, because these two studies in Japan had a research period of 10 years or less, further long-term studies are needed. These previous studies used body weight or BMI as explanatory variables. Unlike these previous studies, this study added abdominal circumference as an explanatory variable along with BMI. As a result, no significant odds ratio was obtained for BMI, but a significant odds ratio was obtained for abdominal circumference. The abdominal circumference is usually considered as an index of the amount of visceral fat, but there are few studies on the relationship between the abdominal circumference and dementia incidence. Further studies using the abdominal circumference as an explanatory variable are needed in the future. In this study, we found that individuals who received insulin injections or oral hypoglycemic medications had a higher risk of dementia incidence. Previous studies have confirmed the progression of hippocampal atrophy in diabetic patients with a long duration of illness, with diabetes reported as a risk factor for dementia in Japan [31,32,33]. In the future, it will be necessary to clarify the contribution rate with higher accuracy and the risk of lifestyle-related diseases, such as diabetes, for the development of dementia in Japan. In such a scenario, the specific health checkups and the specific healthcare guidance currently being conducted for the prevention of metabolic syndrome, may be possibly used for the prevention of dementia. Thus, further, longer duration study with a larger sample is needed to identify the items from the specific health checkups that are associated with the risk of dementia.

5. Conclusions

The findings of our study suggested that a lower abdominal circumference had a higher risk for dementia incidence, and individuals who received insulin injections or oral hypoglycemic medications had a higher risk for dementia incidence based on the results of the health checkups conducted 10 years previously. Further, longer duration study with a larger sample is needed to identify the items from the specific health checkups that are associated with the risk of dementia.
  22 in total

1.  Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.

Authors:  T Matsuzaki; K Sasaki; Y Tanizaki; J Hata; K Fujimi; Y Matsui; A Sekita; S O Suzuki; S Kanba; Y Kiyohara; T Iwaki
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

2.  Does midlife obesity really lower dementia risk?

Authors:  Jorien M M van der Burg; Hanno Pijl; Yvonne J M Campman; Raymund A C Roos; N Ahmad Aziz
Journal:  Lancet Diabetes Endocrinol       Date:  2015-07       Impact factor: 32.069

Review 3.  World dementia: One approach does not fit all.

Authors:  Suvarna Alladi; Vladimir Hachinski
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910

4.  BMI and risk of dementia in two million people over two decades: a retrospective cohort study.

Authors:  Nawab Qizilbash; John Gregson; Michelle E Johnson; Neil Pearce; Ian Douglas; Kevin Wing; Stephen J W Evans; Stuart J Pocock
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-09       Impact factor: 32.069

Review 5.  Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.

Authors:  Omar Yaxmehen Bello-Chavolla; Neftali Eduardo Antonio-Villa; Arsenio Vargas-Vázquez; José Alberto Ávila-Funes; Carlos Alberto Aguilar-Salinas
Journal:  Curr Diabetes Rev       Date:  2019

6.  Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.

Authors:  Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2010-01-28       Impact factor: 5.128

Review 7.  Risk of dementia in diabetes mellitus: a systematic review.

Authors:  Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

8.  Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan.

Authors:  Hiroshi Yokomichi; Akiko Nagai; Makoto Hirata; Yutaka Kiyohara; Kaori Muto; Toshiharu Ninomiya; Koichi Matsuda; Yoichiro Kamatani; Akiko Tamakoshi; Michiaki Kubo; Yusuke Nakamura; Zentaro Yamagata
Journal:  J Epidemiol       Date:  2017-02-03       Impact factor: 3.211

9.  Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals.

Authors:  Mika Kivimäki; Ritva Luukkonen; G David Batty; Jane E Ferrie; Jaana Pentti; Solja T Nyberg; Martin J Shipley; Lars Alfredsson; Eleonor I Fransson; Marcel Goldberg; Anders Knutsson; Markku Koskenvuo; Eeva Kuosma; Maria Nordin; Sakari B Suominen; Töres Theorell; Eero Vuoksimaa; Peter Westerholm; Hugo Westerlund; Marie Zins; Miia Kivipelto; Jussi Vahtera; Jaakko Kaprio; Archana Singh-Manoux; Markus Jokela
Journal:  Alzheimers Dement       Date:  2017-11-21       Impact factor: 21.566

10.  Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study.

Authors:  Hiroshi Yokomichi; Katsunori Kondo; Yuiko Nagamine; Zentaro Yamagata; Naoki Kondo
Journal:  J Diabetes Investig       Date:  2019-07-02       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.